Brief: Cytotools says re-establishes patent protection for DermaPro

bioXXmed AG

16/02/2017 11:07

Feb 16 (Reuters) - Cytotools AG  T5OG.DE : 
    * Opposition proceedings against the European patent for 
active substance DermaPro before the European Patent Office has 
been successfully terminated and active substance patent has 
been fully confirmed 
 
Source text for Eikon:  ID:nEQ59vWy6  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))